ERIBULIN MESYLATE

Eribulin mesylate · Hikma Pharmaceuticals USA Inc.

Drug timelines are a Plus or Pro feature.

44 regulatory and trial events tracked for ERIBULIN MESYLATE, covering 2012-02-09 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer [Phase 2]

See pricing